Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

144.95
Delayed Data
As of Jul 22
 +0.09 / +0.06%
Today’s Change
122.99
Today|||52-Week Range
157.99
-6.21%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close144.86
Today’s open144.41
Day’s range144.10 - 147.00
Volume76,240
Average volume (3 months)234,235
Market cap$6.2B
Dividend yield--
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)+11.67%
Earnings growth (this year)+2.14%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+10.18%
P/E ratio--
Price/Sales6.45
Price/Book3.21

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.41-0.92%
OPKOPKO Health Inc+0.08+0.81%
UTHRUnited Therapeutics ...-1.02-0.91%
MNKMallinckrodt Plc-1.04-1.54%
Data as of 07/22/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$950.8M
Annual profit (last year)$540.9M
Net profit margin56.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts

Partner Offers

Search for Jobs